Vacancies: 01
Education: BSc, MSc, BPharm, MPharm (Specialization in QA)
Experience: Having more than 3 years of Experience in Quality Assurance
Salary: Best in Industry
Mail your resume on : hr@espl.net.in
Job Location: Surat
Vacancies: 01
Education: BSc, MSc, BPharm, MPharm (Specialization in QA)
Experience: Having 1 to 2 years of Experience in Quality Assurance
Salary: Best in Industry
Mail your resume on : hr@espl.net.in
Job Location: Surat
Vacancies: 01
Education: BSc, MSc, (Microbiology)
Experience: Having 1 to 2 years of Experience in Quality Control Department will be an added advantage
Salary: Best in Industry
Mail your resume on : hr@espl.net.in
Job Location: Surat
Vacancies: 01
Education: BBA, MBA, B. Com, M. Com
Experience: Having 1 to 2 years of Experience in Marketing & Sales in Medical/Pharma Industry will be an added advantage
Salary: Best in Industry
Mail your resume on : hr@espl.net.in
Job Location: Ahmedabad
Vacancies: 01
Education: BSc, MSc, Any Graduates with Science Background
Experience: Having 1 to 2 years of Experience in Marketing & Sales in Medical/Pharma Industry will be an added advantage
Salary: Best in Industry
Mail your resume on : hr@espl.net.in
Job Location: Bangalore/ Delhi NCR
A Randomized clinical trial of Abluminus DES+ versus Xience Everolimus-Eluting Stent for Percutaneous Coronary Intervention in patients with Diabetes Mellitus:
An Investigator-Initiated Pilot Study
1. Parts of both stent and balloon are coated
The stent is been coated in a pre-crimped condition and hence both the stent as well as balloon are coated to enhance drug delivery area
2. Treatment of Diffused Lesion and Focal Restenosis
The most complex lesions are been addressed because of the burst release of drug (Balloon) and Programmed release of drug (Stent).
3. Abluminal Coating
The coating is on the abluminal side of the stent which helps in faster re-endothelialization.
4. Hybrid Stent
The stent has a hybrid design platform which comprises of open cells in the mid segment while closed cells at the edge. Hence, has also better bifurcation access area.
5.Thin Bio-absorbable Film – Acute MI
The bio-absorbable film acts as a protective layer and it restrict “slow flow – no flow” movement.
Drug | Polymer | |
---|---|
Drug | Sirolimus |
Drug Dose | 0.70 mcg/mm2 |
Drug Carrier | Lactice and glycolide family of biodegradable polymer |
Stent | |
Stent Material | Cobalt Chromium Alloy L605 |
Strut Thickness | 73 micron (0.0029”) |
Strut Width | 80 micron (hinge) – 120 micron (strut) |
Average Recoil | Less than 5% |
Average Foreshortening | Less than 1% (zero foreshortening design) |
Delivery System | |
Delivery System | Rapid exchange (Rx) stent delivery system |
Nominal Pressure | 8 bar |
Rated Burst Pressure | 14 bar |
The ABILITY RCT is designed to establish long term benefits of unique and innovative product design of Abluminus DES+ in Diabetic indication globally
To compare angiographic and clinical performance of Abluminus DES+ versus Everolimus-eluting DES in patients with diabetes mellitus
In‐stent neointimal volume at 6‐month follow‐up, measured with OCT, following PCI with Abluminus DES+ compared with in‐stent neointimal volume following PCI with Everolimus eluting DES.
Neointimal area, calculated at the site of minimal lumen area at 6-month follow-up measured with OCT.
Target Lesion Failure at 12 months
Stent thrombosis at 12 months
Cardiac death at 12 months
Target vessel myocardial infarction at 12 months
Target lesion revascularization at 12 months
Device success at 24 hours
Lesion success
Procedural success
Interventional cardiologist at San Raffaele Hospital and EMO-GVM Centro Cuore Columbus in Milan Italy.
Dr. Azeem Latib
Director, Cardiac Cath Lab and Interventional Cardiology Unit, EMO GVM Centro Cuore, Columbus and San Raffaele Hospital, Milan, Italy, Visiting Professor of Medicine, Columbia Medical Center
Dr. Antonio Colombo